COVID-19 Vaccine Timeline Expectations Have Become Unrealistic, Warns Porges
Herd Immunity Goal Could Be Years Away
Despite record-breaking speed bringing several vaccine candidates into Phase I trials, the road ahead is likely to be much more treacherous and slow, warns one analyst.
You may also be interested in...
After partnering with Merck KGaA and Cobra Biologics, Oxford University has now tied up with Serum Institute of India to manufacture its COVID-19 vaccine and a marketing pact is likely. With clinical trials of the ChAdOx1 nCoV-19 vaccine underway, Serum intends to set aside other COVID-19 vaccine development plans for the time being.
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.